Medco Builds Outcomes Research Capabilities With REMS Expert United BioSource
This article was originally published in The Pink Sheet Daily
Executive SummaryMedco is adding a new business capability - drug outcomes research for biopharmaceutical companies - with the planned acquisition of information services company United BioSource.
You may also be interested in...
Express Scripts is “looking at strategic alternatives” for some of its non-core businesses, which include international ventures, UBC and PolyMedica.